JPH0314840B2 - - Google Patents

Info

Publication number
JPH0314840B2
JPH0314840B2 JP56061110A JP6111081A JPH0314840B2 JP H0314840 B2 JPH0314840 B2 JP H0314840B2 JP 56061110 A JP56061110 A JP 56061110A JP 6111081 A JP6111081 A JP 6111081A JP H0314840 B2 JPH0314840 B2 JP H0314840B2
Authority
JP
Japan
Prior art keywords
gene
dna
hepatitis
antigen
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56061110A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5739784A (en
Inventor
Teiore Pieeru
Shanii Sharuru
Deyuboa Mariiifuransowaazu
Puuruseru Kurisuchiinu
Ruiizu Annu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ANSUCHI NASHIONARU DO RA SANTE E DO RA RUSHERUSHU MEDEIKARU
ANSUCHI PASUTSUURU
Original Assignee
ANSUCHI NASHIONARU DO RA SANTE E DO RA RUSHERUSHU MEDEIKARU
ANSUCHI PASUTSUURU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ANSUCHI NASHIONARU DO RA SANTE E DO RA RUSHERUSHU MEDEIKARU, ANSUCHI PASUTSUURU filed Critical ANSUCHI NASHIONARU DO RA SANTE E DO RA RUSHERUSHU MEDEIKARU
Publication of JPS5739784A publication Critical patent/JPS5739784A/ja
Publication of JPH0314840B2 publication Critical patent/JPH0314840B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP56061110A 1980-04-22 1981-04-22 Conversion of cell culture Granted JPS5739784A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8009041A FR2480780B1 (fr) 1980-04-22 1980-04-22 Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn

Publications (2)

Publication Number Publication Date
JPS5739784A JPS5739784A (en) 1982-03-05
JPH0314840B2 true JPH0314840B2 (enrdf_load_stackoverflow) 1991-02-27

Family

ID=9241228

Family Applications (2)

Application Number Title Priority Date Filing Date
JP56061110A Granted JPS5739784A (en) 1980-04-22 1981-04-22 Conversion of cell culture
JP61197430A Pending JPS6255095A (ja) 1980-04-22 1986-08-25 ＨＢｓ抗原の形態学的、免疫学的および免疫原的性質を有する抗原の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61197430A Pending JPS6255095A (ja) 1980-04-22 1986-08-25 ＨＢｓ抗原の形態学的、免疫学的および免疫原的性質を有する抗原の製造方法

Country Status (2)

Country Link
JP (2) JPS5739784A (enrdf_load_stackoverflow)
FR (1) FR2480780B1 (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR76274B (enrdf_load_stackoverflow) * 1981-08-04 1984-08-04 Univ California
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS5980615A (ja) * 1982-10-29 1984-05-10 Takeda Chem Ind Ltd Ｄｎａおよびその用途
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
FR2565995B1 (fr) * 1984-03-07 1987-10-23 Centre Nat Rech Scient Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
FR2581393B2 (fr) * 1985-05-02 1989-07-21 Grp Genie Genetique Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit
JP2810364B2 (ja) * 1985-10-04 1998-10-15 ジ・アップジョン・カンパニー 偽狂犬病ウイルス蛋白質
AU599348B2 (en) * 1985-12-18 1990-07-19 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPS63230639A (ja) * 1987-03-19 1988-09-27 Nippon Chem Res Kk 新規なｂ型肝炎ウイルス表面抗原粒子とその製法
JPH0641584Y2 (ja) * 1988-02-24 1994-11-02 株式会社平和 遊技球の振分機構
JP2697753B2 (ja) * 1993-05-24 1998-01-14 昭 田中 直流グロー放電による金属被膜の堆積法
EA200201077A1 (ru) * 2000-04-07 2003-04-24 Юниверсити Оф Лидз Инновэйшнз Лимитед Коровые антигенные химерные белки гепатита в

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO794196L (no) * 1978-12-22 1980-06-24 Biogen Nv Fremgangsmaate ved fremstilling av et rekombinert dna molekyl
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses

Also Published As

Publication number Publication date
FR2480780B1 (fr) 1985-12-06
JPS6255095A (ja) 1987-03-10
JPS5739784A (en) 1982-03-05
FR2480780A1 (fr) 1981-10-23

Similar Documents

Publication Publication Date Title
US5314808A (en) Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
JP2610015B2 (ja) アデノウイルスプロモーターの制御下で所定のポリペプチドをコードしているヌクレオチド配列を含む組換えｄｎａ
Laub et al. Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region
Yuh et al. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus
EP0101617B1 (en) Recombinant dna containing a hepatitis b virus gene, mammalian cells transformed with the cloned viral dna, and production of hepatitis b virus proteins
EP0073656B1 (en) Preparation of polypeptides in vertebrate cell culture
JP2511394B2 (ja) 酵母菌中でのｂ型肝炎表面抗原の製造
EP0244924B1 (en) Production of vaccines against Hepatitis B virus
HK14991A (en) Recombinant dna molecules and their method of production
JPH0314840B2 (enrdf_load_stackoverflow)
Bartenschlager et al. Expression of the P-protein of the human hepatitis B virus in a vaccinia virus system and detection of the nucleocapsid-associated P-gene product by radiolabelling at newly introduced phosphorylation sites
JPH07503615A (ja) 肝炎療剤
JP3621355B2 (ja) 遺伝子治療用組換ｂ型肝炎ウイルスプラスミドベクター
Chang et al. Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus
Wang et al. Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector
US4741901A (en) Preparation of polypeptides in vertebrate cell culture
EP0182442A2 (en) Recombinant DNA molecules and their method of production
EP0062574A2 (en) Virus protein synthesis
US6426216B1 (en) Defective recombinant adenovirus lacking E1A coding sequence and comprising a heterologous nucleotide sequence under control of the E1A promoter
KR960008674B1 (ko) 베리셀라-죠스터 바이러스, 이의 생산방법 및 이를 함유하는 백신
WO1990002176A1 (en) Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders
Denniston et al. Expression of hepatitis B virus surface and e antigen genes cloned in bovine papillomavirus vectors
Rivkina et al. Nucleotide sequence of integrated hepatitis B virus DNA and human flanking regions in the genome of the PLC/PRF/5 cell line
EP0251460B1 (en) Method for producing hepatitis b virus core antigen (hbcag) in yeast
EP0257507A1 (en) Hepatitis vaccine